SELANK 11mg
Documentation: Batch-specific Certificates of Analysis (COAs) are included within the product image gallery for reference.
FOR RESEARCH ONLY
Intended Use: This product is supplied strictly for laboratory research use only. Not for human or veterinary use.
Selank is a synthetic peptide derived from a modified fragment of the endogenous immunomodulatory peptide tuftsin, designed to interact with neurochemical and immunological pathways. In experimental and research contexts, Selank has been investigated for its effects on central nervous system signalling, including modulation of neurotransmitter systems associated with stress and behavioural regulation.
Selank has been studied primarily in non-clinical, preclinical, and limited clinical research settings. At present, Selank is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease or medical condition.
Technical Specifications - SELANK
- Name: Selank (synthetic heptapeptide; analogue of tuftsin)
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
(TKPRPGP; a modified tuftsin fragment) - Molecular Weight: Approx. 807.9 Da
- Molecular Formula: C₃₃H₅₇N₁₁O₉
- CAS Number: 129954-34-3
- Physical Form: Lyophilized (freeze-dried) white to off-white powder (research-grade)
- Purity: Research-grade suppliers typically list ≥ 98–99% purity (HPLC verified)
- Solubility:
• Soluble in sterile water for in-vitro laboratory use
• Soluble in light aqueous buffers
• Gentle mixing recommended to ensure full dissolution
• Avoid strong acids or bases to prevent peptide degradation - Storage / Handling:
• Before reconstitution: Store at –20 °C or colder, protected from light and moisture
• After reconstitution: Store between 2–8 °C and use promptly
• Minimize freeze–thaw cycles; allow vial to reach room temperature before opening to reduce condensation exposure - Intended Application:
Labeled Research Use Only (RUO). Intended for biochemical, in-vitro, or experimental studies related to neurochemical and receptor pathway research.
Not approved for human or veterinary therapeutic use. - General Notes:
Selank is a synthetic analogue of tuftsin investigated in research settings for its influence on neuropeptide signaling, immune–neuro interactions, and stress-related biochemical pathways. All reported effects are based on experimental findings only, and long-term safety or efficacy in humans has not been established outside controlled research environments.
Product Disclaimer
This product is supplied for laboratory research use only. It has not been approved by any national regulatory authority (including the FDA, EMA, or Australian TGA) for human therapeutic, diagnostic, or veterinary use. The purchaser assumes all responsibility for the handling, storage, and disposal of this material in accordance with applicable institutional, local, and national regulations.
The manufacturer/distributor makes no claims regarding the safety, efficacy, or suitability of this material for any medical application or human administration. This product should not be ingested, injected, or otherwise administered to humans or animals except within the context of an approved clinical trial using appropriate GMP-grade material and the required regulatory approvals.
This product should be handled only by qualified personnel trained in laboratory safety and reagent handling. Keep out of reach of children. Improper use may cause harm. The product is supplied “as is”, with no warranty, express or implied, regarding fitness for a particular purpose. Users should review available safety data and consult institutional safety officers prior to use.
